Friday, October 10, 2008

Paul Sullivan's Legacy: An Early Warning Program For Detecting Melanoma Before It's Too Late

Paul Sullivan's Legacy: An Early Warning Program For Detecting Melanoma Before It's Too Late
The Melanoma Foundation of New England and the Boston University School of Medicine are co-sponsoring an Accreditation Council for Continuing Medical Education (ACCME) course to update non-dermatologists on the detection and management of melanoma.

Prescient Medical, Inc. Presents Clinical And Preclinical Findings For VProtect(TM) Luminal Shield And VPredict(TM) Optical Catheter System
TCT 2008 attendees will be among the first to hear a report on initial clinical experiences with the vProtect(TM) Luminal Shield in patients with non-flow-limiting "vulnerable" plaques.

Paper In Cell Cycle Reports Alfacell's ONCONASE(R) Targets SiRNA
Alfacell Corporation (Nasdaq: ACEL) announced that a paper published in Cell Cycle (2008; Vol. 7, Issue 20) reports that ONCONASE (ranpirnase) targets small interfering RNA (siRNA), likely within the RNA-induced silencing complex (RISC) of the RNA interference (RNAi) mechanism.

CDC Awards $16.9 Million to Combat Pandemic, Seasonal Influenza
The Centers for Disease Control and Prevention (CDC) has awarded a $16.9 million contract to American Type Culture Collection (ATCC) of Manassas, Va. to implement the CDC Influenza Reagent Resource (CDC-IRR), a secure, Web-based system that will improve access to influenza viruses, test kits and other reagents for approved laboratories.

0 comments: